0 results available. Select is focused ,type to refine list, press Down to open the menu,
VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company’s lead program is repibres...
The following section summarizes insights on Vyne Therapeutics Inc's Total Debt:
We've identified the following companies as similar to Vyne Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Total Debt in the financials category include:
The sum of all debt and capital lease obligations.
VYNE Therapeutics reported total debt of 99 T for the latest quarter ending December 31, 2024 on its balance sheet.
The tables below summarizes VYNE Therapeutics’s Total Debt and common size over the last five years:
Fiscal Year | Total Debt | Assets | % Assets |
---|---|---|---|
2020-12-31 | 34.784 M | 93.742 M | 37.1% |
2021-12-31 | 349 T | 67.046 M | 0.5% |
2022-12-31 | zero | 40.758 M | 0.0% |
2023-12-31 | 214 T | 97.685 M | 0.2% |
2024-12-31 | 99 T | 66.905 M | 0.1% |
The tables below summarizes VYNE Therapeutics’s Total Debt and common size over the last four quarters:
Quarter Ending | Total Debt | Assets | % Assets |
---|---|---|---|
2024-03-31 | 180 T | 91.676 M | 0.2% |
2024-06-30 | 145 T | 86.648 M | 0.2% |
2024-09-30 | 123 T | 76.198 M | 0.2% |
2024-12-31 | 99 T | 66.905 M | 0.1% |
The chart above depicts the distribution of total debt for companies operating in the Healthcare sector in the Developed economic region. Over 2,465 companies were considered in this analysis, and 2,422 had meaningful values. The average total debt of companies in the sector is 255 M with a standard deviation of 1.033 B.
Vyne Therapeutics Inc's Total Debt of 99 K ranks in the 16.1% percentile for the sector. The following table provides additional summary stats:
Economic Risk Region | Developed |
Total Constituents | 2,470 |
Included Constituents | 2,422 |
Min | 0 K |
Max | 10.671 B |
Median | 6.169 M |
Mean | 255 M |
Standard Deviation | 1.033 B |
You can find companies with similar total debt using this stock screener.